C. Ogwulu

Mifepristone and misoprostol versus placebo and misoprostol for resolution of miscarriage in women diagnosed with missed miscarriage: the MifeMiso RCT.

C. Bottomley, A. Coomarasamy, Yongzhong Sun, 2021, Health technology assessment.

Ending preventable stillbirths 3 Stillbirth: Why invest?

Keelin O'Donoghue, Tracy Roberts, Soo Downe, 2018 .

The valuation of outcomes for the temporary and chronic health states associated with Chlamydia trachomatis infection

Philip Kinghorn, T. Roberts, Louise J. Jackson, 2021, medRxiv.

Stillbirths: economic and psychosocial consequences

Louise J Jackson, Jai K. Das, Z. Bhutta, 2016, The Lancet.